The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Malignant hyperthermia: a review
Open accessAbstract
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that presents as a hypermetabolic response to potent volatile anesthetic gases such as halothane, sevoflurane, desflurane, isoflurane and the depolarizing muscle relaxant succinylcholine, and rarely, in humans, to stressors such as vigorous exercise and heat. The incidence of MH reactions ranges from 1:10,000 to 1: 250,000 anesthetics. However, the prevalence of the genetic abnormalities may be as great as one in 400 individuals. MH affects humans, certain pig breeds, dogs and horses. The classic signs of MH include hyperthermia, tachycardia, tachypnea, increased carbon dioxide production, increased oxygen consumption, acidosis, hyperkalaemia, muscle rigidity, and rhabdomyolysis, all related to a hypermetabolic response. The syndrome is likely to be fatal if untreated. An increase in end-tidal carbon dioxide despite increased minute ventilation provides an early diagnostic clue. In humans the syndrome is inherited in an autosomal dominant pattern, while in pigs it is autosomal recessive. Uncontrolled rise of myoplasmic calcium, which activates biochemical processes related to muscle activation leads to the pathophysiologic changes. In most cases, the syndrome is caused by a defect in the ryanodine receptor. Over 400 variants have been identified in the RYR1 gene located on chromosome 19q13.1, and at least 34 are causal for MH. Less than 1 % of variants have been found in CACNA1S but not all of these are causal. Diagnostic testing involves the in vitro contracture response of biopsied muscle to halothane, caffeine, and in some centres ryanodine and 4-chloro-m-cresol. Elucidation of the genetic changes has led to the introduction of DNA testing for susceptibility to MH. Dantrolene sodium is a specific antagonist and should be available wherever general anesthesia is administered. Increased understanding of the clinical manifestation and pathophysiology of the syndrome, has lead to the mortality decreasing from 80 % thirty years ago to <5 % in 2006.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SIFT: predicting amino acid changes that affect protein function
Ng, P. C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg509 · Cited by 6,577
Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2
Adzhubei, I., Jordan, D. M., & Sunyaev, S. R. (2013) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0720s76 · Cited by 3,705
Automated inference of molecular mechanisms of disease from amino acid substitutions
Li, B., Krishnan, V. G., Mort, M. E., Xin, F., Kamati, K. K., Cooper, D. N., Mooney, S. D., & Radivojac, P. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp528 · Cited by 826
Temperature Monitoring and Perioperative Thermoregulation
Sessler, D. I., Warner, D. S., & Warner, M. A. (2008) · Anesthesiology · doi:10.1097/aln.0b013e31817f6d76 · Cited by 758
Functional annotations improve the predictive score of human disease-related mutations in proteins
Calabrese, R., Capriotti, E., Fariselli, P., Martelli, P. L., & Casadio, R. (2009) · Human Mutation · doi:10.1002/humu.21047 · Cited by 690
A Clinical Grading Scale to Predict Malignant Hyperthermia Susceptibility
Larach, M. G., Localio, A. R., Allen, G. C., Denborough, M. A., Ellis, F. R., Gronert, G. A., Kaplan, R. F., Muldoon, S. M., Nelson, T. E., Ørding, H., et al. (1994) · Anesthesiology · doi:10.1097/00000542-199404000-00008 · Cited by 572
Self-citationHypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle
Bellinger, A. M., Reiken, S., Carlson, C., Mongillo, M., Liu, X., Rothman, L., Matecki, S., Lacampagne, A., & Marks, A. R. (2009) · Nature Medicine · doi:10.1038/nm.1916 · Cited by 531
Mutations in RYR1 in malignant hyperthermia and central core disease
Robinson, R., Carpenter, D., Shaw, M.-A., Halsall, J., & Hopkins, P. (2006) · Human Mutation · doi:10.1002/humu.20356 · Cited by 502
PMUT: a web-based tool for the annotation of pathological mutations on proteins
Ferrer-Costa, C., Gelpi, J. L., Zamakola, L., Parraga, I., de la Cruz, X., & Orozco, M. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti486 · Cited by 496
A PROTOCOL FOR THE INVESTIGATION OF MALIGNANT HYPERPYREXIA (MH) SUSCEPTIBILITY
(1984) · British Journal of Anaesthesia · doi:10.1093/bja/56.11.1267 · Cited by 439
Cited by
Patel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W., Angelos, P., Chen, H., Doherty, G. M., Fahey, T. J., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003580 · Cited by 541
European Resuscitation Council Guidelines 2021: Paediatric Life Support
Van de Voorde, P., Turner, N. M., Djakow, J., de Lucas, N., Martinez-Mejias, A., Biarent, D., Bingham, R., Brissaud, O., Hoffmann, F., Johannesdottir, G. B., et al. (2021) · Resuscitation · doi:10.1016/j.resuscitation.2021.02.015 · Cited by 448
Targeting thermogenesis in brown fat and muscle to treat obesity and metabolic disease
Betz, M. J., & Enerbäck, S. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.132 · Cited by 355
Skeletal muscle thermogenesis and its role in whole body energy metabolism
Periasamy, M., Herrera, J. L., & Reis, F. C. G. (2017) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2017.41.5.327 · Cited by 230
Ketamine applications beyond anesthesia – A literature review
Nowacka, A., & Borczyk, M. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172547 · Cited by 129
Metadata
- Authors
- Rosenberg, H., Pollock, N., Schiemann, A., Bulger, T., & Stowell, K.
- Venue
- Orphanet Journal of Rare Diseases
- Published
- 2015-08-04
- Volume
- 10
- Issue
- 1
- Pages
- 93-93
- ISSN
- 1750-1172 (ISSN-L)
- OpenAlex
- W2146587884
- Cited by
- 597
- References
- 114
- FWCI
- 48.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Malignant hyperthermia: a review. https://app.cochat.ai/papers/10.1186/s13023-015-0310-1
- The paper
- Rosenberg, H., Pollock, N., Schiemann, A., Bulger, T., & Stowell, K. (2015). Malignant hyperthermia: a review. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/s13023-015-0310-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.